Source link : https://newshealth.biz/health-news/blenrep-returns-adc-combo-approved-for-r-r-mm/
Belantamab mafodotin remains in development, with its maker, GlaxoSmithKline, aiming for an upfront MM indication. Medscape Medical News Source link : https://www.medscape.com/viewarticle/blenrep-returns-adc-combo-approved-r-r-mm-2025a1000t27?src=rss Author : Publish date : 2025-10-24 16:01:00 Copyright for syndicated content belongs to the linked Source.
The post Blenrep Returns: ADC Combo Approved for R/R MM first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-24 16:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8